Source: New feed
[at Barrons.com] - Folks, my apologies for the slight delay: Over the transom only late…
Biotech: Never Give Up
Wall Street Journal (subscription) (blog)
Perseverance is an admirable trait. Cancer drug developer XBiotech provides a case in point. The biotech company announced Friday afternoon that its late stage study for its experimental colon cancer treatment, Xilonix, has been discontinued after an ...
and more »